Kronos Bio, Inc. (KRON) Misses Q2 EPS by 6c

Kronos Bio, Inc. (NASDAQ: KRON) reported Q2 EPS of ($0.52), $0.06 worse than the analyst estimate of ($0.46). Revenue for the quarter came in at $1.86 million versus the consensus estimate of $1.67 million.

For earnings history and earnings-related data on Kronos Bio, Inc. (KRON) click here.

You May Also Be Interested In

• Okta upgraded as AI security opportunity boosts outlook
• Similarweb Ltd. (SMWB) Tops Q2 EPS by 3c
• Performance Food Group (PFGC) Misses Q4 EPS by 1c ; Offers Guidance